Advertisement
Screener

AIM IMMUNOTECH INC. (AIM) Debt / Equity

AIM IMMUNOTECH INC. (AIM) Debt / Equity

  • 2026-06-30: Debt/Equity Ratio 0.94.
  • 2026-03-31: Debt/Equity Ratio 1.98.
  • 2025-12-31: Debt/Equity Ratio -0.46.
  • 2025-06-30: Debt/Equity Ratio -0.77.

Complete source-backed debt/equity ratio history.

Available history
2018-03-31 to 2026-06-30
Data captured

Historical Debt/Equity Ratio

DateDebt/Equity Ratio
2026-06-300.94
2026-03-311.98
2025-12-31-0.46
2025-06-30-0.77
2025-03-31-1.12
2024-12-31-3.87
2024-09-300.94
2024-06-300.43
2024-03-310.53
2021-03-310.03
2020-12-310.03
2020-09-300.04
2020-06-300.05
2020-03-310.06
2019-12-310.17
2019-09-300.18
2019-06-300.37
2019-03-310.63
2018-12-310.45
2018-09-300.4
2018-06-300.29
2018-03-310.26

Annual Debt/Equity Ratio

DateDebt/Equity Ratio
2025-12-31-0.46
2024-12-31-3.87
2020-12-310.03
2019-12-310.17
2018-12-310.45

Similar stocks

Stock NameCountryMarket CapPE Ratio
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
VivoSim Labs, INC. (VIVS)United States$0.003B
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
CURIS INC (CRIS)United States$0.002B-0.05
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
Silexion Therapeutics Corp (SLXN)$0.001B